RAAFAT E F FAHIM Insider Trading $VXRT Vaxart, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for RAAFAT E F FAHIM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of RAAFAT E F FAHIM. RAAFAT E F FAHIM is President, CEO and CFO in Aviragen Therapeutics, Inc. ($NABI).
RAAFAT E F FAHIM in Vaxart, Inc.
Trading Symbol: VXRTIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of RAAFAT E F FAHIM: President, CEO and CFO
Holdings: 373,474 shares
Current Value: $425,760
Latest Transaction: Apr 05 2011
$VXRT Market Capitalization: $43.28M
$VXRT Previous Close: $1.14
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of RAAFAT E F FAHIM in Vaxart, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 05 2011 | NABI | Aviragen Therapeut ... | FAHIM RAAFAT E F | President, CEO and ... | Option Exercise | A | 5.81 | 150,000 | 871,500 | 150,000 | |
Apr 05 2011 | NABI | Aviragen Therapeut ... | FAHIM RAAFAT E F | President, CEO and ... | Sell | S | 5.76 | 13,283 | 76,458 | 373,474 | 386.8 K to 373.5 K (-3.43 %) |
Apr 05 2011 | NABI | Aviragen Therapeut ... | FAHIM RAAFAT E F | President, CEO and ... | Grant | A | 0.00 | 50,000 | 0 | 386,757 | 336.8 K to 386.8 K (+14.85 %) |
Apr 05 2011 | NABI | Aviragen Therapeut ... | FAHIM RAAFAT E F | President, CEO and ... | Buy | J | 4.30 | 3,023 | 12,999 | 336,757 | 333.7 K to 336.8 K (+0.91 %) |
Apr 05 2011 | NABI | Aviragen Therapeut ... | FAHIM RAAFAT E F | President, CEO and ... | Buy | J | 4.20 | 3,096 | 13,003 | 333,734 | 330.6 K to 333.7 K (+0.94 %) |
Jan 07 2011 | NABI | Aviragen Therapeut ... | FAHIM RAAFAT E F | President, CEO and ... | Sell | S | 5.65 | 3,181 | 17,973 | 330,638 | 333.8 K to 330.6 K (-0.95 %) |
Apr 05 2010 | NABI | Aviragen Therapeut ... | FAHIM RAAFAT E F | President, CEO and ... | Option Exercise | A | 5.49 | 125,000 | 686,250 | 125,000 | |
Apr 05 2010 | NABI | Aviragen Therapeut ... | FAHIM RAAFAT E F | President, CEO and ... | Grant | A | 0.00 | 50,000 | 0 | 333,819 | 283.8 K to 333.8 K (+17.62 %) |
Apr 05 2010 | NABI | Aviragen Therapeut ... | FAHIM RAAFAT E F | President, CEO and ... | Buy | J | 2.41 | 5,404 | 12,999 | 283,819 | 278.4 K to 283.8 K (+1.94 %) |
Apr 05 2010 | NABI | Aviragen Therapeut ... | FAHIM RAAFAT E F | President, CEO and ... | Buy | J | 2.41 | 5,404 | 12,999 | 278,415 | 273 K to 278.4 K (+1.98 %) |
Apr 03 2009 | NABI | Aviragen Therapeut ... | FAHIM RAAFAT E F | President, CEO and ... | Option Exercise | A | 3.78 | 115,000 | 434,700 | 115,000 | |
Apr 03 2009 | NABI | Aviragen Therapeut ... | FAHIM RAAFAT E F | President, CEO and ... | Grant | A | 0.00 | 45,000 | 0 | 270,064 | 225.1 K to 270.1 K (+19.99 %) |
Page: 1